Side-by-side comparison of AI visibility scores, market position, and capabilities
Jakarta Indonesia UTBK university entrance exam preparation platform for 800K+ annual test-takers with live classes and MURI record-setting online tryouts; competing with Ruangguru and Zenius for Indonesia edtech exam prep market leadership.
Pahamify is a Jakarta, Indonesia-based educational technology company — providing Indonesian high school students with comprehensive preparation for the UTBK-SNBT (Seleksi Nasional Berbasis Tes, the Indonesian university entrance examination) through live interactive classes, recorded video lessons, adaptive practice questions, AI-powered learning analytics, and full-length mock exams. Founded in 2018 and holding the MURI (Museum Rekor Indonesia) world record for hosting the largest online tryout exam participation, Pahamify has established itself as one of Indonesia's leading UTBK preparation platforms with hundreds of thousands of student users across the country. The platform serves the approximately 800,000 Indonesian students who take the UTBK-SNBT annually in competition for limited spots at public universities.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.